lifestyle.smsolar.net

Author: PANTHERx Specialty, LLC

PANTHERx® Rare Pharmacy Earns 2026 MMIT Patient Choice Award for Patient Satisfaction

April 28, 2026
PANTHERx® Rare Selected by UCB as the Exclusive Specialty Pharmacy for the Distribution of KYGEVVI™

March 23, 2026
PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)

March 20, 2026
As Rare Disease Drug Approvals Accelerate, PANTHERx® Releases Research on Strengthening Care Coordination

February 25, 2026
PANTHERx® Rare Selected by Otsuka to Dispense VOYXACT® (sibeprenlimab-szsi) for the Treatment of Primary Immunoglobulin A Nephropathy

December 20, 2025